Clinical Study
Retrospective Analysis of Cushing’s Disease with or without Hyperprolactinemia
Table 3
Preoperative clinical manifestations in the two groups of patients.
| Symptom | CD ( = 48) | PRL + CD ( = 36) | P |
| Headache/dizziness | 27 (56.3%) | 24 (66.7%) | 0.333 | Progressive obesity | 21 (43.8%) | 6 (16.7%) | 0.009 | Vomiting | 4 (8.3%) | 4 (11.1%) | 0.720 | Visual impairment | 19 (39.6%) | 18 (50.0%) | 0.341 | Visual field defects | 6 (12.5%) | 12 (33.3%) | 0.021 | Menstrual disorders | 16/28 (57.1%) | 22/26 (84.6%) | 0.027 | Galactorrhea | 10/28 (35.7%) | 14/26 (53.8%) | 0.180 | Sexual dysfunction | 4/10 (40.0%) | 2/20 (10.0%) | 0.141 | Polyuria/polydipsia | 12 (25.0%) | 8 (22.2%) | 0.767 | Hypertension | 40 (83.3%) | 10 (27.8%) | <0.001 | Diabetes mellitus | 5 (10.4%) | 6 (16.7%) | 0.523 |
|
|
Data are expressed as (%). values were determined using a chi-square test. P < 0.05 was considered statistically significant.
|